• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging

tetano

Editor, Senior Moderator
Vaccine. 2017 Oct 28. pii: S0264-410X(17)31481-0. doi: 10.1016/j.vaccine.2017.10.073. [Epub ahead of print]
[h=1]A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging.[/h] Stockwell MS[SUP]1[/SUP], Marchant CD[SUP]2[/SUP], Wodi AP[SUP]3[/SUP], Barnett ED[SUP]4[/SUP], Broder KR[SUP]5[/SUP], Jakob K[SUP]6[/SUP], Lewis P[SUP]7[/SUP], Kattan M[SUP]8[/SUP], Rezendes AM[SUP]9[/SUP], Barrett A[SUP]10[/SUP], Sharma D[SUP]11[/SUP], Fernandez N[SUP]12[/SUP], LaRussa P[SUP]13[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Using text messaging for vaccine safety monitoring, particularly for non-medically attended events, would be valuable for pandemic influenza and emergency vaccination program preparedness. We assessed the feasibility and acceptability of text messaging to evaluate fever and wheezing post-influenza vaccination in a prospective, observational, multi-site pediatric study.
[h=4]METHODS:[/h] Children aged 2-11 years old, with an emphasis on children with asthma, were recruited during the 2014-2015 influenza season from three community-based clinics in New York City, and during the 2014-2015 and 2015-2016 seasons from a private practice in Fall River, Massachusetts. Parents of enrolled children receiving quadrivalent live attenuated (LAIV4) or inactivated influenza vaccine (IIV4) replied to text messages assessing respiratory symptoms (day 3 and 7, then weekly through day 42), and temperature on the night of vaccination and the next seven nights (day 0-7). Missing data were collected via diary (day 0-7 only) and phone. Phone confirmation was obtained for both presence and absence of respiratory symptoms. Reporting rates, fever (T≥100.4 ?F) frequency, proportion of wheezing and/or chest tightness reports captured via text message versus all sources (text, phone, diary, electronic health record) and parental satisfaction were assessed.
[h=4]RESULTS:[/h] Across both seasons, 266 children were analyzed; 49.2% with asthma. Parental text message response rates were high (>70%) across sites. Overall, fever frequency was low (day 0-2: 4.1% [95% confidence interval (CI) 2.3-7.4%]; d3-7: 6.7% [95% CI 4.1-10.8%]). A third (39.2%) of parents reported a respiratory problem in their child, primarily cough. Most (88.2%) of the 52 wheezing and/or chest tightness reports were by text message. Most (88.1%) participants preferred text messaging over paper reporting.
[h=4]CONCLUSIONS:[/h] Text messaging can provide information about pediatric post-vaccination fever and wheezing and was viewed positively by parents. It could be a helpful tool for rapid vaccine safety monitoring during a pandemic or other emergency vaccination program.
[h=4]TRIAL REGISTRATION:[/h] clinicaltrials.gov Identifier: NCT02295007.
Copyright ? 2017 Elsevier Ltd. All rights reserved.


[h=4]KEYWORDS:[/h] Asthma; Influenza; Influenza vaccination; SMS; Text message; Vaccination; Vaccine safety; Wheeze

PMID: 29089191 DOI: 10.1016/j.vaccine.2017.10.073
 
Back
Top Bottom